Status:
COMPLETED
Probiotics for Irritable Bowel Syndrome
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
Mejeribrugets ForskningsFond
Arla Foods
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The study aims to investigate the effect of probiotics on IBS-patients symptoms compared to placebo, when given for 6 months. By draw the investigators give IBS patients, in the age of 18-50 years, c...
Detailed Description
Background: In management of IBS, no treatments have showed great efficacy. IBS is a non-fatal disease, so safety is a high priority in the choice of treatment. Probiotics is a dietary supplement and ...
Eligibility Criteria
Inclusion
- Fulfill ROME III criteria
- age 18-50 years
- signed informed content
Exclusion
- Danger signals (fever, anaemia, weightloss, blod in stools, predisposition for CRC or IBD)
- abnormal physical examination
- comorbidity
- abuse
- lacking ability to talk and understand danish
- pregnancy
- For patients \> 40 years. Changed bowel habits, with duration \> 3 weeks, but \< 1 year
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01151657
Start Date
January 1 2009
End Date
June 1 2011
Last Update
October 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Unit for General Practice, Department of gastroenterology, Odense University hospital
Odense, Odense, Denmark, 5000